Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Diabetes 14, 481493
It's the result of execution, innovation, and a once-in-a-generation product portfolio
This distinguishes Wegovy from some other diabetes medications, such as SGLT2 inhibitors (sodium-glucose co-transporter-2 inhibitors), which are known to increase UTI risk through their mechanism of increasing urinary glucose excretion
1 Peter Boesman, XC323082
and practical and safety considerations for the use of GLP-1 RAs
16 17 18 Newly emerging indications for GLP-1 medicationsincluding heart disease, metabolic liver disease, peripheral artery disease, Alzheimers/dementia risk, and even alcohol and substance use disorders, as highlighted in a 2025 study in JAMA 19 suggest these drugs may soon play a much broader role in medicine than just treating diabetes or obesity
US$ 23.75
US$ 26.06
US$ 20.13
